(Q46614109)

23 December 2017

title

Pharmacokinetics of bolus 5-fluorouracil: relationship between dose, plasma concentrations, area-under-the-curve and toxicity (English)

1 reference

23 December 2017

1 reference

1 reference

Codacci-Pisanelli G

1

1 reference

23 December 2017

Pinedo HM

2

1 reference

23 December 2017

Lankelma J

3

1 reference

23 December 2017

Van Groeningen CJ

4

1 reference

23 December 2017

Van Kuilenburg AB

5

1 reference

23 December 2017

Van Gennip AH

6

1 reference

23 December 2017

Peters GJ

7

1 reference

23 December 2017

publication date

1 June 2005

1 reference

23 December 2017

published in

Journal of Chemotherapy

1 reference

23 December 2017

volume

17

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

315-320

1 reference

23 December 2017

5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

Different intravenous administration techniques for 5-fluorouracil. Pharmacokinetics and pharmacodynamic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

Radiochemical assay for determination of dihydropyrimidinase activity using reversed-phase high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

High-dose 5-Fluorouracil with uridine-diphosphoglucose rescue increases thymidylate synthase inhibition but not 5-Fluorouracil incorporation into RNA in murine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.3.315

10.1179/JOC.2005.17.3.315

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017